May 16 (Reuters) - British drugmaker GSK said on Thursday it plans to sell about 385 million shares, representing its entire shareholding, in spun-off consumer healthcare business Haleon. (Reporting by Anchal Rana in Bengaluru; Editing by Shilpi Majumdar)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,652 GBX | +0.06% | -4.57% | +13.85% |
Jun. 05 | HSBC Lifts GSK PT, Maintains Reduce Rating | MT |
Jun. 05 | Berenberg raises Taylor Wimpey to 'buy' | AN |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,652 GBX | +0.06% | -4.54% | 85.94B | ||
329.2 GBX | +0.43% | +1.53% | 38.22B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.88% | 85.94B | |
+42.69% | 749B | |
+38.85% | 605B | |
-6.87% | 351B | |
+18.74% | 328B | |
+6.76% | 292B | |
+18.89% | 248B | |
-2.41% | 214B | |
+11.16% | 216B | |
+2.64% | 167B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK intends to sell its entire stake in Haleon